News | Breast Density | November 15, 2018 | Jeff Zagoudis, Associate Editor

Breast Density Advocate Nancy M. Cappello Passes Away

Cappello’s work to inform women about the risks of dense breast tissue led to density inform laws in 35 states

Breast Density Advocate Nancy M. Cappello Passes Away

Nancy Cappello. Image courtesy of AreYouDense.org.

November 15, 2018 — Imaging Technology News extends its condolences to the family, friends and colleagues of Nancy M. Cappello, Ph.D., who could be called the founder of the breast density education movement in the U.S., on her passing on Nov. 15. A breast cancer survivor herself, Cappello passed away from secondary myelodyspastic syndrome (MDS), a bone marrow cancer that was a complication of her prior aggressive breast cancer treatments.

Cappello was diagnosed with stage 3C breast cancer in February 2004, just six weeks after her annual mammogram came up normal. Her doctor told her that the cancer was missed on the mammogram because she had dense fibroglandular breast tissue, a concept that was little-known among patients at that time. Dense breast tissue appears white on a traditional 2-D mammogram, which can mask cancers that also show up as white. Women with extremely dense breast tissue are five times more likely to have breast cancer compared to women with fatty breasts. 

Wanting to make sure other women had access to this critical information to make more informed decisions about their healthcare, Cappello founded the nonprofit organizations Are You Dense Inc. and Are You Dense Advocacy in 2008. The group’s aims are four-fold:

  1. Educate the public about breast health and the impact of dense breast tissue
  2. Improve the condition of those diagnosed with breast cancer through education
  3. Advocate changes to public policy about the prevention and treatment of breast cancer, including breast cancer screening guidelines
  4. Support new and existing research about the prevention and treatment of breast cancer and the causal and screening risks of dense breast tissue and its impact on advanced disease

One of the group’s most visible efforts has been working with state legislatures to enact laws requiring mammography facilities to inform patients about their breast density and the associated cancer risks. Cappello started with the legislature in her home state of Connecticut, playing an instrumental part in the passage of the first breast density inform law in 2009. Since then, 36 states have passed some form of density notification legislation, with others in progress. Are You Dense and Are You Dense Advocacy have also been working with Congress to enact a national density inform law that would allow greater standardization among the states.  

Cappello’s latest medical battles began in September, according to her own blog post on AreYouDense.org. She was admitted to the hospital after feeling increasingly weak, to the point where she could not stand or walk for more than 1 minute without sitting down. Three weeks later, the diagnosis of secondary MDS was confirmed following a bone marrow biopsy. She had been awaiting a bone marrow transplant after it was determined none of her three siblings were a match.

“I am on a quest to expose this best-kept secret of dense breast tissue to ensure that women with dense breast tissue receive screening and diagnostic measures to find cancer at its earliest stage — isn’t that the purpose of screening programs?” she wrote on the AreYouDense website.

"Nancy was the originator of the dense breast tissue movement starting in Connecticut then across the nation and around the world. We believe she alone and the legislation she helped craft in 36 states has saved many lives," said Donna Johnson, president of Are You Dense Inc. in a statement. "Nancy's work is not over. Are You Dense Inc. and Are You Dense Advocacy Inc. will continue to work on a national breast density notification law and work on the remaining states one by one."

“Nancy Cappello was the inspiration behind the first #BreastDensity legislation in Connecticut in 2009. She will continue to inspire us to question the status quo and strive to do better,” said Wendy Ingman, Ph.D., associate professor in breast biology and cancer at the University of Adelaide, Australia, on Twitter.

“We lost Nancy Cappello, founder of RU Dense, today due to complications related to treatment of bc [breast cancer]. A brave woman whose actions truly made a difference!” said Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre, and professor of medical biophysics and medical imaging, University of Toronto.

Click through the links below to see ITNtv interviews with Cappello, as well as pieces she contributed to the magazine.

VIDEO: The Impact of Breast Density Technology and Legislation

VIDEO: Personalized Breast Screening and Breast Density

VIDEO: Breast Cancer Awareness - Highlights of the NCoBC 2016 Conference

Fake News: Having Dense Breast Tissue is No Big Deal

The Manic World of Social Media and Breast Cancer: Gratitude and Grief

Related Content

VolparaEnterprise data analysis shows mammography screening volumes are quickly increasing
News | Mammography | June 09, 2020
June 9, 2020 — More than 75 percent of hospitals and imaging centers that perform mammography across the United State
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 09, 2020 | By Melinda Taschetta-Millane
Developed by medical AI company Lunit, Software detects breast cancer with 97% accuracy; Study in Lancet Digital Health shows that Lunit INSIGHT MMG-aided radiologists showed an increase in sensitivity

Lunit INSIGHT MMG

News | Artificial Intelligence | June 02, 2020
June 2, 2020 — Lunit announced that its artificia...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
Phone call and linkage-to-care-based intervention increases mammography uptake among primary care patients at an urban safety-net hospital

Getty Images

News | Mammography | May 22, 2020
May 22, 2020 — Telephone outreach coupled with scheduling assistance significantly increased...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur
Podcast: Impact of COVID-19 on Breast Cancer Treatment with Dr. Andrea Madrigrano

Kubtec hosts a Podcast: Impact of COVID-19 on Breast Cancer Treatment with Andrea Madrigrano, M.D., as part of its public service campaign.

News | Coronavirus (COVID-19) | May 06, 2020
May 6, 2020 — The COVID-19 pandemic is an unprec